Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma

Transarterial chemoembolization (TACE) is a widely used treatment for hepatocellular carcinoma. In order to maximize its therapeutic efficacy, doxorubicin-loaded drug-eluting beads have been developed to deliver higher doses of the chemotherapeutic agent and to prolong contact time with the tumor. T...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of hepatology Vol. 57; no. 6; pp. 1244 - 1250
Main Authors:	Song, Myeong Jun, Chun, Ho Jong, Song, Do Seon, Kim, Hee Yeon, Yoo, Sun Hong, Park, Chung-Hwa, Bae, Si Hyun, Choi, Jong Young, Chang, U Im, Yang, Jin Mo, Lee, Hae Giu, Yoon, Seung Kew
Format:	Journal Article
Language:	English
Published:	Kidlington Elsevier B.V 01.12.2012 Elsevier
Subjects:	Aged Antibiotics, Antineoplastic - administration & dosage Antibiotics, Antineoplastic - adverse effects Biological and medical sciences Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - therapy Chemoembolization, Therapeutic Conventional TACE DC bead® TACE Disease Progression Doxorubicin - administration & dosage Doxorubicin - adverse effects Female Gastroenterology and Hepatology Gastroenterology. Liver. Pancreas. Abdomen Humans Liver Neoplasms - mortality Liver Neoplasms - therapy Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Middle Aged Retrospective Studies Survival Rate Time to progression Treatment response Tumors PR RECIST BCLC TACE cTACE Time to progression HCC DC bead Treatment response RFA Conventional TACE CR SD PD RCTs DEBDOX DC bead® TACE progressive disease Response Evaluation Criteria in Solid Tumors drug-eluting bead conventional TACE stable disease DC bead® loaded with doxorubicin randomized controlled studies transarterial chemoembolization partial response hepatocellular carcinoma Barcelona Clinic for Liver Cancer complete response radiofrequency ablation Antineoplastic agent Prognosis Hepatic disease Hepatocellular carcinoma Doxorubicin Isomerases Gastroenterology Evolution DNA topoisomerase (ATP-hydrolysing) Enzyme Enzyme inhibitor Instrumentation therapy Topoisomerase II inhibitor Malignant tumor Antibiotic Digestive diseases Embolization Anthracyclins Comparative study Cancer Chemoembolization
ISSN:	0168-8278, 1600-0641, 1600-0641
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!